(4R,8R)-1-methyl-8-[(1-methylimidazol-2-yl)methylamino]-N-[(5-methyl-1,2-oxazol-3-yl)methyl]-2-oxoazonane-4-carboxamide
C20H30N6O3 — CID 75529726
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4R,8R)-1-methyl-8-[(1-methylimidazol-2-yl)methylamino]-N-[(5-methyl-1,2-oxazol-3-yl)methyl]-2-oxoazonane-4-carboxamide
(4R,8R)-1-methyl-8-[(1-methylimidazol-2-yl)methylamino]-N-[(5-methyl-1,2-oxazol-3-yl)methyl]-2-oxoazonane-4-carboxamide (PubChem CID 75529726) has the molecular formula C20H30N6O3 and a molecular weight of 402.50 g/mol. Its IUPAC name is (4R,8R)-1-methyl-8-[(1-methylimidazol-2-yl)methylamino]-N-[(5-methyl-1,2-oxazol-3-yl)methyl]-2-oxoazonane-4-carboxamide.
Molecular Properties
| Compound Name | (4R,8R)-1-methyl-8-[(1-methylimidazol-2-yl)methylamino]-N-[(5-methyl-1,2-oxazol-3-yl)methyl]-2-oxoazonane-4-carboxamide |
|---|---|
| PubChem CID | 75529726 |
| Molecular Formula | C20H30N6O3 |
| Molecular Weight | 402.50 g/mol |
| Exact Mass | 402.24 |
| IUPAC Name | (4R,8R)-1-methyl-8-[(1-methylimidazol-2-yl)methylamino]-N-[(5-methyl-1,2-oxazol-3-yl)methyl]-2-oxoazonane-4-carboxamide |
| SMILES | Cc1cc(CNC(=O)[C@@H]2CCC[C@@H](NCc3nccn3C)CN(C)C(=O)C2)no1 |
| InChI | InChI=1S/C20H30N6O3/c1-14-9-17(24-29-14)11-23-20(28)15-5-4-6-16(13-26(3)19(27)10-15)22-12-18-21-7-8-25(18)2/h7-9,15-16,22H,4-6,10-13H2,1-3H3,(H,23,28)/t15-,16-/m1/s1 |
| InChIKey | FJXNLJMFXBNKSZ-HZPDHXFCSA-N |
| XLogP | 1.14 |
| TPSA | 105.29 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 402.50 |
| LogP ≤ 5 | 1.14 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 75529726 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.